NASDAQ:ALXO
ALX Oncology Holdings Inc.
- Stock
Last Close
14.66
17/05 20:00
Market Cap
734.33M
Beta: 1.66
Volume Today
188.72K
Avg: 271.68K
PE Ratio
−4.46
PFCF: −6.91
Dec '18 | Dec '19 | Dec '20 | Dec '21 | Dec '22 | Dec '23 | ||
|---|---|---|---|---|---|---|---|
net income | -13.73M - | -19.24M 40.14% | -45.74M 137.70% | -83.46M 82.47% | -123.48M 47.95% | -160.81M 30.23% | |
depreciation and amortization | 431K - | 429K 0.46% | 202K 52.91% | 51K 74.75% | 342K 570.59% | 836K 144.44% | |
deferred income tax | 1.27M - | -458K - | |||||
stock based compensation | 269K - | 297K 10.41% | 5.44M 1,730.30% | 13.91M 155.96% | 23.84M 71.33% | 26.27M 10.21% | |
change in working capital | -159K - | 4.26M 2,777.36% | 247K 94.20% | -4.03M 1,730.36% | 9.85M 344.60% | 8.30M 15.77% | |
accounts receivables | 396K - | 536K 35.35% | |||||
inventory | -396K - | -536K 35.35% | |||||
accounts payables | -269K - | 2.98M 1,206.32% | -3.74M 225.81% | 3.29M 187.87% | 4.51M 36.96% | 458K 89.84% | |
other working capital | 110K - | 1.28M 1,064.55% | 3.99M 211.55% | -7.32M 283.34% | 5.34M 173.04% | 7.84M 46.69% | |
other non cash items | 11K - | 295K 2,581.82% | 5.42M 1,738.64% | 228K 95.80% | -4.51M 2,076.75% | ||
net cash provided by operating activities | -13.19M - | -14.25M 8.03% | -38.29M 168.71% | -68.10M 77.86% | -89.22M 31.02% | -130.36M 46.11% | |
investments in property plant and equipment | -653K - | -353K 45.94% | -31K 91.22% | -4.92M 15,780.65% | -1.43M 71.01% | -1.27M 10.72% | |
acquisitions net | 641K - | 233.99K - | |||||
purchases of investments | -376.79M - | -246.63M 34.54% | |||||
sales maturities of investments | 142.80M - | 292.56M 104.87% | |||||
other investing activites | -233.99K - | ||||||
net cash used for investing activites | -653K - | -353K 45.94% | 610K 272.80% | -4.92M 907.05% | -235.42M 4,681.96% | 44.66M 118.97% | |
debt repayment | -6.51M - | -281K 95.68% | -388K 38.08% | -388K 0% | |||
common stock issued | 7K - | 10K 42.86% | 368.26M 3,682,460% | 2.75M 99.25% | 567K 79.40% | 59.68M 10,425.40% | |
common stock repurchased | -6K - | 3K - | 202K 6,633.33% | 336K 66.34% | 523K 55.65% | ||
dividends paid | -3K - | -2.75M 91,666.67% | -59.68M - | ||||
other financing activites | 15.35M - | 101.13M 558.96% | 2.55M 97.48% | 9.35M 266.33% | 59.16M 533.02% | ||
net cash used provided by financing activities | 1K - | 15.36M 1,535,600% | 462.88M 2,914.14% | 2.47M 99.47% | 9.86M 298.87% | 59.29M 501.33% | |
effect of forex changes on cash | |||||||
net change in cash | -13.84M - | 755K 105.45% | 425.20M 56,218.15% | -70.55M 116.59% | -314.78M 346.17% | -26.42M 91.61% | |
cash at beginning of period | 22.10M - | 8.26M 62.62% | 9.02M 9.14% | 434.22M 4,715.56% | 363.67M 16.25% | 48.82M 86.58% | |
cash at end of period | 8.26M - | 9.02M 9.14% | 434.22M 4,715.56% | 363.67M 16.25% | 48.89M 86.56% | 22.41M 54.17% | |
operating cash flow | -13.19M - | -14.25M 8.03% | -38.29M 168.71% | -68.10M 77.86% | -89.22M 31.02% | -130.36M 46.11% | |
capital expenditure | -653K - | -353K 45.94% | -31K 91.22% | -4.92M 15,780.65% | -1.43M 71.01% | -1.27M 10.72% | |
free cash flow | -13.84M - | -14.60M 5.48% | -38.32M 162.43% | -73.02M 90.56% | -90.65M 24.14% | -131.64M 45.22% |
All numbers in USD (except ratios and percentages)